CDC publishes national COVID-19 analysis using Truveta Data
The FDA just changed the rules. Here’s what we owe patients.
With the FDA ending the two-trial default, the era of intelligent evidence has begun
Truveta Live Link: Enabling more complete real-world evidence and prospective research
Truveta experts: Antidepressant treatment duration trends
Real-world evidence on heart failure from GLP-1 and advanced CKD populations
More than a third of patients on Wegovy pill are new to GLP-1 drugs, study finds
Early uptake of oral semaglutide for obesity (Wegovy pill) following FDA approval
